HIV-1 CROSS-NEUTRALIZING ANTIBODIES IN GERMAN HIV-1-INFECTED PATIENTS DO NOT CORRELATE WITH AN ANTIBODY-BINDING PATTERN AGAINST DIFFERENT HIV-1 ISOLATES

被引:0
作者
JURKIEWICZ, E [1 ]
PETRY, H [1 ]
SUTOR, GC [1 ]
LANG, S [1 ]
SCHEDEL, I [1 ]
HUNSMANN, G [1 ]
机构
[1] HANNOVER MED SCH,D-30625 HANNOVER,GERMANY
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:91 / 93
页数:3
相关论文
共 17 条
[1]   HIGH PREVALENCE OF ANTIBODIES TO THE GP120 V3 REGION PRINCIPAL NEUTRALIZING DETERMINANT OF HIV-1MN IN SERA FROM AFRICA AND THE AMERICA [J].
CARROW, EW ;
VUJCIC, LK ;
GLASS, WL ;
SEAMON, KB ;
RASTOGI, SC ;
HENDRY, RM ;
BOULOS, R ;
NZILA, N ;
QUINNAN, GV .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (10) :831-838
[2]  
DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615
[3]   LAV/HTLV-III NEUTRALIZING ANTIBODIES IN THE SERA OF PATIENTS WITH AIDS, LYMPHADENOPATHY SYNDROME AND ASYMPTOMATIC SEROPOSITIVE INDIVIDUALS [J].
FAULKNERVALLE, GP ;
DEROSSI, A ;
GASSA, OD ;
CHIECOBIANCHI, L .
TUMORI, 1986, 72 (03) :219-224
[4]   3 NEW POTENT HIV-1 INHIBITORS FROM MYXOBACTERIA [J].
JURKIEWICZ, E ;
JANSEN, R ;
KUNZE, B ;
TROWITZSCHKIENAST, W ;
FORCHE, E ;
REICHENBACH, H ;
HOFLE, G ;
HUNSMANN, G .
ANTIVIRAL CHEMISTRY & CHEMOTHERAPY, 1992, 3 (04) :189-193
[5]  
KATZENSTEIN DA, 1990, J ACQ IMMUN DEF SYND, V3, P810
[6]   PERSISTENT HIV ANTIGENEMIA AND DECLINE OF HIV CORE ANTIBODIES ASSOCIATED WITH TRANSITION TO AIDS [J].
LANGE, JMA ;
PAUL, DA ;
HUISMAN, HG ;
DEWOLF, F ;
VANDENBERG, H ;
COUTINHO, RA ;
DANNER, SA ;
VANDERNOORDAA, J ;
GOUDSMIT, J .
BRITISH MEDICAL JOURNAL, 1986, 293 (6560) :1459-1462
[7]   DEVELOPMENT OF HIV-1 GROUP-SPECIFIC NEUTRALIZING ANTIBODIES AFTER SEROCONVERSION [J].
MCKNIGHT, A ;
CLAPHAM, PR ;
GOUDSMIT, J ;
CHEINGSONGPOPOV, R ;
WEBER, JN ;
WEISS, RA .
AIDS, 1992, 6 (08) :799-802
[8]   RESTRICTION OF SERUM ANTIBODY REACTIVITY TO THE V3 NEUTRALIZING DOMAIN OF HIV GP120 WITH PROGRESSION TO AIDS [J].
PAGE, M ;
VELLA, C ;
CORCORAN, T ;
DILGER, P ;
LING, C ;
HEATH, A ;
THORPE, R .
AIDS, 1992, 6 (05) :441-446
[9]  
RANKI A, 1987, CLIN EXP IMMUNOL, V69, P231
[10]  
RINALDO C, 1989, J CLIN MICROBIOL, V27, P880, DOI 10.1128/JCM.27.5.880-884.1989